RFK Jr. Nomination for HHS Sparks Mixed Reactions and Concerns
TL;DR Summary
Pharmaceutical stocks have plummeted following Donald Trump's nomination of Robert F. Kennedy Jr., a known anti-vaccine activist, to lead the US Department of Health and Human Services. RFK Jr.'s controversial views on vaccines and health-related conspiracy theories have sparked investor panic, leading to significant declines in shares of major pharmaceutical companies like Moderna, AstraZeneca, and GSK. His nomination has been widely criticized, with concerns about potential impacts on public health infrastructure and vaccine distribution.
- Pharma shares hit as Trump picks RFK Jr to lead health department The Guardian
- Democratic Colorado governor commends Trump for nominating RFK Jr. as HHS secretary Fox News
- RFK Jr.’s to-do list to make America ‘healthy’ has health experts worried CNN
- Late Night Feels Queasy About America’s Next Health Czar, R.F.K. Jr. The New York Times
- Trump to select Robert F. Kennedy Jr. to lead HHS POLITICO
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
2 min
vs 3 min read
Condensed
86%
536 → 74 words
Want the full story? Read the original article
Read on The Guardian